Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Asset Writedowns and Impairment (2016 - 2026)

Kewaunee Scientific has reported Asset Writedowns and Impairment over the past 17 years, most recently at $79000.0 for Q1 2026.

  • Quarterly results put Asset Writedowns and Impairment at $79000.0 for Q1 2026, down 18.56% from a year ago — trailing twelve months through Jan 2026 was -$4000.0 (down 102.37% YoY), and the annual figure for FY2025 was $68000.0, down 75.36%.
  • Asset Writedowns and Impairment for Q1 2026 was $79000.0 at Kewaunee Scientific, up from -$50000.0 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for KEQU hit a ceiling of $125000.0 in Q3 2023 and a floor of -$52000.0 in Q2 2025.
  • Median Asset Writedowns and Impairment over the past 5 years was $41000.0 (2023), compared with a mean of $35647.1.
  • Peak annual rise in Asset Writedowns and Impairment hit 1028.57% in 2022, while the deepest fall reached 520.0% in 2022.
  • Kewaunee Scientific's Asset Writedowns and Impairment stood at -$31000.0 in 2022, then soared by 293.55% to $60000.0 in 2023, then crashed by 80.0% to $12000.0 in 2024, then plummeted by 516.67% to -$50000.0 in 2025, then skyrocketed by 258.0% to $79000.0 in 2026.
  • The last three reported values for Asset Writedowns and Impairment were $79000.0 (Q1 2026), -$50000.0 (Q4 2025), and $19000.0 (Q3 2025) per Business Quant data.